New diabetes jab shows significant weight and blood sugar reduction

A new weekly injection, retatrutide, shows promise in reducing blood sugar and body weight in type 2 diabetes patients, according to phase 3 trial results. Participants lost over four times as much weight compared to those on placebo, with blood sugar levels dropping more than twice as much. Further testing is needed to confirm these findings.

Read the full story at The Guardian AU→